Case Report: Direct Access Genetic Testing and A False-Positive Result For Long QT Syndrome

Journal of Genetic Counseling

Volumn 25, Issue 1, 2016, Pages 25-31

  Predham, Sarah ^a   Hamilton, Sara ^a   Elliott, Alison M ^a,b   T Gibson, William ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Direct access genetic testing; False positive; Health economics; Long QT syndrome; Positive predictive value; Public policy; Secondary findings; Testing accuracy

Indexed keywords

CASE REPORT; ECONOMICS; FALSE POSITIVE RESULT; FEMALE; GENETIC SCREENING; GENETICS; HEALTH CARE COST; HUMAN; LONG QT SYNDROME;

FALSE POSITIVE REACTIONS; FEMALE; GENETIC TESTING; HEALTH CARE COSTS; HUMANS; LONG QT SYNDROME;

EID: 84955683493     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-015-9882-0     Document Type: Article

References (35)

1. 23andMe – Canada. DNA Genetic Testing & Analysis (2015). Retrieved from https://store.23andme.com/en-ca/cart/?utm_campaign=CA_Search-Branded+&utm_term=20_dollar_promo&gclid=Cj0KEQiA0aemBRC8p87zv_mc5qYBEiQAiEEMQVVWz3z2Qmiv9GdzZcuuUyCZS8JiXwXu4arIvUoa66YaAjWr8P8HAQ&utm_content=23c_Search_Paid_Brand&utm_source=google&utm_medium=cpc. Accessed 29 Jan 2015.
2. 23andMe – UK. DNA Genetic Testing & Analysis (2015). Retrieved from https://www.23andme.com/en-gb/?utm_source=google&utm_medium=cpc&utm_campaign=GB_Search-Branded&utm_content=23c_Search_Paid_Brand&gclid=Cj0KEQiA0aemBRC8p87zv_mc5qYBEiQAiEEMQcbVZ5W_gK6tp7DVIb608DyOClS_l_6ZTpgY7vamNSYaAi3b8P8HAQ. Accessed 29 Jan 2015.
3. Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace, 13, 1077–1109.
4. Amendola, L. M., Dorschner, M. O., Robertson, P. D., Salama, J. S., Hart, R., Shirts, B. H., et al. (2015). Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Research, 25, 305–315.
5. Aviva Health UK Limited (2012). Retrieved April 4, 2015 from http://www.aviva.co.uk/health-insurance/practitioner-zone/online-fee-schedule/.
6. Bloss, C. S., Darst, B. F., Topol, E. J., & Schork, N. J. (2011). Direct-to-consumer personalized genomic testing. Human Molecular Genetics, 20, 132–141.
7. Borry, P., van Hellemondt, R. E., Sprumont, D., Jales, C. F. D., Rial-Sebbag, E., Spranger, T. M., Curren, L., et al. (2012). Legislation on direct-to-consumer genetic testing in seven European countries. European Journal of Human Genetics, 20, 715–721.
8. Centers for Medicare and Medicaid Services. (2015). Retrieved May 26, 2015 from https://www.cms.gov/Medicare/Medicare-Fee-for-ServicePayment/FeeScheduleGenInfo/ index.html?redirect=/FeeScheduleGenInfo.
9. Christenhusz, G. M., Devriendt, K., & Dierickx, K. (2013). To tell or not to tell; A systematic review of ethical reflections on incidental findings arising in genetics contexts. European Journal of Human Genetics, 21, 248–255.
10. Company Bankruptcy Information for Existence Genetics, LLC. (n.d.). Retrieved February 13, 2015, from http://business-bankruptcies.com/cases/existence-genetics-llc.
11. Darst, B. F., Madlensky, L., Schork, N. J., Topol, E. J., & Bloss, C. S. (2013). Perceptions of genetic counseling services in direct‐to‐consumer personal genomic testing. Clinical Genetics, 84, 335–339.
12. Fair Health Consumer Cost Lookup. (2015). Retrieved May 26, 2015 from Fairhealthconsumer.org/medical_cost.php.
13. Federal Executive Council of the Commonwealth of Australia. (2014). Government of Australia Health Insurance (General Medical Services Table) Regulation 2014. Retrieved April 4, 2015 from http://www.comlaw.gov.au/Details/F2014L00713.
14. Gollob, M. H. (2011). Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Canadian Journal of Cardiology, 27, 232–245.
15. Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15, 565–575.
16. Gutierrez, A. (2013). United States Department of Health and Human Services Public Health Service Food and Drug Administration warning letter CMS 415534 Document Number: GEN1300666 Re: Personal Genome Service (PGS). [Online Letter dated 22 Nov 2013]. Retrieved from http://www.fda.gov/iceci/enforcementactions/warningletters/2013/ucm376296.htm.
17. Harris, A., Kelly, S. E., & Wyatt, S. (2013). Counselling customers: emerging roles for genetic counselors in the direct-to-consumer genetic testing market. Journal of Genetic Counseling, 22, 277–288.
18. Hogarth, S., Javitt, G., & Melzer, D. (2008). The current landscape for direct-to consumer genetic testing: legal, ethical, and policy issues. Annual Review of Genomics and Human Genetics, 9, 161–182.
19. Ingles, J., Zodgekar, P. R., Yeates, L., Macciocca, I., Semsarian, C., & Fatkin, D. (2011). Guidelines for genetic testing of inherited cardiac disorders. Cardiac Genetic Testing, 20, 681–687.
20. Kaufman, D. J., Bollinger, J. M., Dvoskin, R. L., & Scott, J. A. (2012). Risky buisness: risk perception and the use of medical services among customers of DTC personal genetic testing. Journal of Genetic Counseling, 21, 413–422.
21. Kohane, I., Masys, D., & Altman, R. (2006). The incidentalome: a threat to genomic medicine. Journal of the American Medical Association, 296, 212–215.
22. Lohn, Z., Adam, S., Birch, P. H., & Friedman, J. M. (2013). Incidental findings from clinical genome-wide sequencing: a review. Journal of Genetic Counseling, 23, 463–473.
23. Medical Services Commission (2014). Medical Services Plan Payment Schedule-Cardiology. Retrieved April 4, 2015 from http://www2.gov.bc.ca/gov/DownloadAsset?assetId=B9632FD375554883BF60413D8167959B&filename=13-cardiology.pdf.
24. Morita, H., Wu, J., & Zipes, D. P. (2008). The QT syndromes: long and short. Lancet, 372, 750–763.
25. Myers, M. (2011). Health care providers and direct-to-consumer access and advertising of genetic testing in the United States. Genome Medicine, 3, 81.
26. Nakano, Y., & Shimizu, W. (2015). Genetics of long-QT syndrome. Journal of Human Genetics, 1–5.
27. NSGC Headquarters. (19 June 2015). Direct access to genetic testing position statement. Retrieved July 8, 2015 from: http://nsgc.org/p/bl/et/blogaid=370.
28. Pundi, K. N., Bos, J. M., Cannon, B. C., & Ackerman, M. J. (2015). Automated extrenal defibrillator rescues among children with diagnosed and treated long QT syndrome. Heart Rhythm, 4, 776–781.
29. Roberts, J. S., & Ostergren, J. (2013). Direct-to-consumer genetic testing and personal genomics services: a review of recent empirical studies. Current Genetic Medicine Reports, 1, 182–200.
30. Sanfilippo, P. G., Kearns, L. S., Wright, P., Mackey, D. A., & Hewitt, A. W. (2015). Current landscape of direct‐to‐consumer genetic testing and its role in ophthalmology: a review. Clinical & Experimental Ophthalmology.
31. Su, P. (2013). Direct-to-consumer genetic testing: a comprehensive view. Yale Journal of Biology and Medicine, 86, 359–365.
32. The Education, Ethics and Public Policy committee of the Canadian College of Medical Geneticists (CCMG). Direct-to-consumer (DTC) genetic testing in this country. Letter to Health Canada. [Online letter dated 19 July 2015]. Retrieved from: http://www.ccmg-ccgm.org/index.php/news-article-11.html?id=230amp;catid=122.
33. van den Berg, S., Shen, Y., Jones, S. J. M., & Gibson, W. T. (2014). Genetic counseling in direct-to-consumer exome sequencing: a case report. Journal of Genetic Counseling, 23, 742–53.
34. Vrecar, I., Peterlin, B., Teran, N., & Lovrecic, L. (2015). Direct-to-consumer genetic testing in Slovenia: availability, ethical dilemmas and legislation. Biochemia Medica, 5, 84–89.
35. Weaver, M., & Pollin, T. I. (2012). Direct-to-consumer genetic testing: what are we talking about? Journal of Genetic Counseling, 21, 361–366.